The d gene from the Bacillus subtilis temperate bacteriophage SP,3 was isolated. When introduced into an SP,l-sensitive strain of B. subtilis, the cloned d gene directed the synthesis of a 22-kilodalton protein and conferred on the host immunity to SP,i phage. A frameshift mutation, designated d2, was introduced into the cloned d gene, and it was subsequently crossed back into the SPI8 phage genome. The ml when needed, was used as a plating medium for phage and bacteria.
Bacillus subtilis 168 and most of its derivatives are lysogenic for the temperate bacteriophage SP, (18) . This omnipresence of the SP,B prophage implies the existence of an efficient mechanism for the establishment and maintenance of lysogeny. The available data indicate that the repressor protein encoded by the c gene plays a central role in the establishment of lysogeny by turning off lytic-cycle genes (16, 18) . Wild-type SP, (c+) phage can be induced by mitomycin C; it replicates at temperatures below 50TC and forms cloudy plaques on sensitive bacteria (16) . The SP, phage carrying the thermoinducible repressor gene (SP, c2) also forms cloudy plaques under normal growth temperature, but when in the prophage state it can be induced by a brief heat shock of the lysogens at 50°C (13) . In contrast, clear-plaque mutants such as SP,B cl are unable to lysogenize sensitive B. subtilis strains and therefore form clear plaques. Double lysogens containing both the cl and c2 prophages can be heat induced, while those containing c+ and c2 cannot (13) . Thus, the c gene encodes a trans-acting repressor protein involved in the establishment and maintenance of lysogeny. All the clear-plaque mutants so far tested fall within the same complementation group (18) . In our attempt to clone the repressor gene from the 126-kilobase (kb) phage genome, we uncovered a new genetic element involved in controlling phage lysogeny and immunity. The biochemical and biological characterization of the cloned d gene is reported here.
MATERIALS AND METHODS
Bacterial strains and media. The bacterial strains, phages, and plasmids used are listed in Table 1 . The liquid media used were TB (1% tryptone [Difco Laboratories, Detroit, Mich.], 0.5% NaCI) and modified M (1% tryptone [Difco] , 0.5% yeast extract, 1% NaCl, 5 mM CaC12, 5 mM MgSO4, 0.02 mM MnCl2) as described previously (12) . Modified M medium was used for growing B. subtilis cells and preparing phage lysates. TBA soft agar (TB containing 0.7% agar) was used when determining phage titers. Tryptose blood agar base (TBAB; Difco), containing 5 ,ug of chloramphenicol per * Corresponding author. ml when needed, was used as a plating medium for phage and bacteria.
Phage growth and DNA preparation. Phage SPI c2 was prepared from strain CU1147 by the heat induction method essentially as described by Rosenthal et al. (13) . Wild-type SP,B phage was prepared either by mitomycin C (0.8 ,ug/ml) induction or, as for SP3 clO (described below), by growing phages lytically by the method of Warner et al. (16) with the following modifications: (i) the adsorption period at 37°C was 15 to 20 min; (ii) the centrifugation step to remove unadsorbed phage was omitted; and (iii) infected cells were diluted 30-to 100-fold into prewarmed (37°C) modified M medium.
Purified phage particles were prepared by the method of Fink et al. (3) with several modifications. Polyethylene glycol 6000 was added to 10% (wt/vol) to the phage suspension along with NaCl to 0.5 M to precipitate most of the phage particles. Polyethylene glycol-precipitated phage pellets were suspended in CsCl (1.497 g/ml, in a 10 mM trischloride [pH 7.4]-2 mM MgSO4-10 mM CaC12 buffer) without attempting to remove the trace amount of polyethylene glycol and centrifuged to equilibrium with a Beckman Ti 70.1 rotor at 24,500 rpm for 28 h or with a VTi8O rotor at 60,000 rpm for 6.5 h at 18°C. After collection and dialysis of the phage band, phage suspensions were concentrated, and the phage DNA was extracted with TE (10 mM Trischloride [pH 8.0], 1 mM EDTA) buffer-saturated phenol followed by two chloroform extractions and ethanol precipitation.
Isolation of clear-plaque SP13 c1O. During the preparation of SPI c+ phage from the SU+3 (SP1) strain, a spontaneous clear-plaque phage (designated SP, c1O) was fortuitously identified. In all the tests performed, SP clO was indistinguishable from SP, cl; they were both used in these studies.
PHAGE SP,B d GENE (5) and chromosomal (2) DNAs was essentially as previously reported. DNA restriction fragments were separated on either polyacrylamide or agarose slab gels, depending on their size, and electroeluted as described previously (7), except that the buffers used were 0.05 x TBE for acrylamide and 0.1 x TEA (4 mM Trischloride [pH 8 .0], 0.1 mM EDTA, 0.5 mM sodium acetate) for agarose gels.
Site-directed mutagenesis was carried out as described previously (20) . A synthetic oligonucleotide with the sequence 5'-GATATATTTTCATAAGCTTGGAATCAGAT- 3 ' was used to modify the d gene sequence around nucleotide position 405. Other methods for molecular cloning in E. coli were essentially as described previously (7) .
Determination of DNA sequence. Appropriate DNA fragments were cloned into the M13 phage vectors mplO and mpll (10) . Single-stranded DNA templates were prepared, and the DNA sequence was determined on both strands by the dideoxyribonucleotide chain termination method (14, 15) with [a-35S] Tests for SPO lysogeny and immunity. To look for the presence of SPi prophage, we tested the B. subtilis strains by the method described by Rosenthal et al. (13) for their immunity to clear-plaque mutants of SP,, their ability to release phage particles, or their ability to produce betacin. Transformants of CU1050 carrying various plasmids were tested for their immunity to SP13 by streaking transformant colonies across a vertical line along which 1 x 108 to 2 x 108 SP clO phage had been applied on a TBAB plate containing 5 ,ug of chloramphenicol per ml (19) . CU1050 cells carrying only the vector pLP1201 were lysed on plates after infection by SP, clO phage and thus served as the negative control; they grew only on the first half of the cross streak. CU1050(SPP c2) cells carrying pLP1201 served as the positive control which grew across the entire streak.
Crossing the d2 frameshift mutation back into the SPI8 phage genome. Cells of CU1147, a strain lysogenic for SP13 c2 phage, were made competent and then transformed with pJM172, the plasmid containing the ClaI-to-NruI +2 frameshift mutation in d. One of the transformants was used to inoculate 5 ml of TB containing 5 ,ug of chloramphenicol per ml and grown for 5 to 6 h. The titer of the supernatant containing phage particles was determined on a lawn of CU1050(pLP1201) cells. Spontaneous release of SP13 phage was between 106 and 107 PFU/ml. Of approximately 104 plaques screened visually, 2 clear plaques were picked. One of these was plaque purified through three plating cycles. The clear-plaque phage isolated was then grown up (500 ml) and gradient purified as described above. Phage DNA was extracted, and the presence of the d2 allele was confirmed by analysis of restriction endonuclease digestions for the presence of the diagnostic NruI site. VOL. 167, 1986 on October 28, 2017 by guest http://jb.asm.org/
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To construct the SP, cl d2 double mutant, CU1050 (pJM172) cells were spotted with SP, cl lysate on a plate. After overnight incubation, phage from the cleared zone were collected and plated on CU1050 indicator cells. Cloudy, but distinctively smaller, plaques appeared at a frequency of about lo-3, These phage were plaque purified, and the presence of the d2 allele on the genomes was confirmed as described above.
RESULTS
Molecular cloning of the d gene from SPj( c2. A gene library of SP, c2 genome cloned into the bifunctional plasmid pLP1201 was constructed (see Materials and Methods). Competent B. subtilis CU1050 cells were transformed with plasmids prepared from the pooled cultures. Individual transformants were then tested for SP, clO immunity by the cross-streaking test. Of 234 transformants tested, 15 showed immunity. Plasmid DNA from six of these was prepared and analyzed. Three of the six appeared to have identical restriction patterns for EcoRI, PstI, and Sall, while the other three differed but appeared to be related clones that had suffered deletions presumably outside of the cloned immunity gene sequence. The restriction map of one of the undeleted candidates, designated pJM135, is shown in Fig. 1 . Since the phage genome was digested with BamHI and BglII and the vector was cleaved with BamHI, we checked pJM135 plasmid DNA for the presence of regenerated BamHI sites. No BamHI recognition sites were present at either junction with pLP1201 DNA. Therefore, most likely the cloned fragment in pJM135 was derived from a 5.9-kb BglII fragment in the SP, c2 genome. The cloned gene that confers immunity was designated the d gene.
Mapping (Fig. 1 ) had no effect on the immunity phenotype of the transformants. In contrast, transformants carrying plasmids lacking either the 3.9-kb ClaI fragment [Clal(l) to ClaI(2) in Fig. 1 ] or the 4.5-kb ClaI fragment [ClaI (2) to ClaI(3) in Fig. 1 ] from pJM135 lost the immunity to phage infection. It therefore seemed likely that the d gene spans the ClaI(2) site.
In vitro construction of frameshift mutations in the d gene. Mapping data revealed the presence of multiple ScaI and PstI sites in the cloned SPP fragment in pJM135 (Fig. 1) . The 2.9-kb Pst(l) to ScaI(2) fragment ( Fig. 1 ) generated'by partial PstI digestion and complete Scal digestion was cloned into PstI-and SmaI-digested pUC18 plasmid (10) . The resulting plasmid was designated pJM154. This plasmid has a unique ClaI restriction site within the SP, DNA insert (Fig. 1) . After ClaI digestion and repair with E. coli DNA polymerase Klenow fragment, these molecules were ligated and used for transforming E. coli MM294. The transformants were screened for the generation of a NruI site that would result from the ligation of completely repaired ClaI ends. The majority of the plasmids had lost the ClaI site and gained an NruI site; one of these clones was designated pJM169. The minority of the resulting plasmids had neither a ClaI nor an NruI site; one of these was designated pJM158. The 1,033-base-pair (bp) PstI-EcoRI fragment from each of these plasmids (pJM154, pJM158, and pJM169) was purified by electroelution from 4% acrylamide gels and ligated to PstIand EcoRI-digested pLP1201 to replace the small PstIEcoRI fragment carrying most of the pBR322 ,B-lactamase gene. Aps Tcr transformants were screened by restriction digestion to ensure the presence of the SPP DNA insert, and the resulting plasmids were designated pJM160 (d+; with ClaI site), pJM170 (d-; without CMa), and pJM172 (d-; with NruI replacing CMl).
B. subtilis CUlOSO transformants carrying pJM160 were immune to SP, c+ as well as SP clO and other SPBcphage. In contrast, CU1050(pJM170) and CU1050(pJM172) did not confer immunity to these phage. From these data we conclude that the d gene resides within the 1-kb PstI-EcoRI fragment and that the ClaI site is located within the d gene.
DNA sequence of the PstI-EcoRI fragment of SP( phages. The sequencing strategy used to determine the DNA sequence of the SP, PstI-EcoRI fragment is shown in Fig. 2 . The 1,033-base sequence of the antisense strand of this fragment isolated from SPpi c2 phage is shown from the 5'-end PstI site to the 3'-end EcoRI site in Fig. 3 . A long open reading frame exists from position 135 through 815 within which is located the ClaI site (position 666). Four AUG (Met) and one GUG (Val) codons cou,ld be the initiation site for the d gene protein (Fig. 3) . In addition to the sequence of the d gene shown in Fig. 3 , the sequence of the insertion mutants at the ClaI site was also determined. A synthetic 17-mer oligonucleotide was used as the sequencing primer to determine the nucleotide sequence surrounding the ClaI site regions in pJM154, pJM158, and pJM169. The sequence across the ClaI site in pJM154 was 5'. . .TAT,ATC,GAT,TTT,CTC,. .3' (Fig. 3) . The ClaI site was apparently only partially repaired, resulting in a + 1 frameshift mutation in the d gene on pJM158. The properly repaired ClaI ends were ligated and generated a +2 frameshift mutation and an NruI site (TCGCGA) in the d gene on pJM169. We designate the alleles with the +1 and +2 frameshift mutations dl and d2, respectively.
The same PstI-EcoRI fragment was also isolated from the SP,B cl, c1O, and c+ genomes by cloning into the coliphage M13mplO vector. The sequences of these fragments were analyzed. They were all identical to that isolated from SPP CTGCAGATTAT(,TCAAAGAACTGCTCATTCAGATAAAATCAGAAAAGAACTAATGATTTCACTTTCCATrTATACAGrTCTCCATGACTGGAAACAATGGTATAATGTAGGAAAATGATA Fig. 3 .
The sequence downstream from the GUG codon at nucleotide position 405 consists of an open reading frame of 137 codons. This 137-amino acid polypeptide was used as the antigen to raise antiserum. To achieve this, we carried out oligonucleotide-directed site-specific mutagenesis to convert the GUG codon at position 405 (Fig. 3) (Fig. 4) Genetic analyses of SPjI phage carrying the d2 mutation. We crossed the d2 allele into the SP, c2 genome and studied the phenotype of the SPP c2 d2 phage (see Materials and Methods). Two clear-plaque phages were identified among the spontaneously released phages from CU1147(pJM172) transformants. Phage DNA from one of these clones was isolated and analyzed. The presence of an additional NruI site that is diagnostic of the d2 allele confirmed that the phage indeed carried the d2 mutation. The genome of the clear-plaque phage contained two NruI sites approximately 6.6 kb apart (Fig. SA, lane b) instead of a single site found in the c2 phage genome (Fig. SA, lane b) . Thus, the d2 mutation causes the clear-plaque phenotype in the SP3 c2 d2 phage.
We also crossed the d2 mutation into the lytic phage SPP cl J. BACTERIOL. (see Materials and Methods). The SP,B cl d2 phage formed smaller and cloudy plaques on a CU1050 lawn. The cells within the plaques were isolated and further characterized.
They appeared to be lysogenic to SPP phage since they spontaneously released phage particles and produced betacin. However, these lysogens were very unstable. Upon several transfers by streaking on plates, cured cells appeared at high frequency. This cl d2 phage is phenotypically similar to the int-SP,B phage that forms abortive lysogens as described by Zahler (18) . The main difference is that the cl d2 phage forms cloudy plaques in the absence of a functional repressor gene owing to the cl mutation.
The clear-plaque SPP c2 d2 phage was further tested for complementation with SPP cl by mixed infection. When the mixed lysate was spotted on the CU1050 lawn and incubated overnight, the clear zone appeared to be the same as those seem with either phage lysate alone; only scattered phageresistant colonies grew within the lysis zones. Upon further incubation for a few hours, a thin film of bacteria could be detected in the lysis zone spotted with the mixed lysate, but not with the individual lysates. These cells were picked and purified by repeated streaking. All of them spontaneously released cloudy-plaque phage morphologically similar to the SPP c2 phage. In addition, of 10 independently isolated phage tested, none carried the diagnostic NruI site unique to the d2 mutation. Thus, these cells were lysogenic for SP, c2 that was generated by recombination between the cl and the c2 d2 phage.
Physical mapping of the d gene. The sequencing primer complementary to the internal sequence of the d gene (nucleotide positions 608 to 624 in Fig. 3 ) was used to probe the genomes of strains carrying defective SP3 prophages.
Southern analysis data are shown in Fig. 6 . The probe reacted to the total DNA isolated from CU1050(SPP c2) (strain CU1147 (Fig. 5A, lane d) being cleaved into two fragments of about 9.7 and 7.5 kb (Fig. 5A, lane e) . The additional NruI site in the clear-plaque mutant c2 d2 also maps in the SalI D fragment. Similar double digestion produced two fragments of about 6.6 and 3 kb (Fig. 5A, lane f) from the original 9.7-kb SaII-NruI fragment of SP,B c2 DNA (Fig. 5A , lane e).
Further mapping of the NruI sites with respect to the PstI recognition sequences indicated that the unique NruI site in the SP, c2 genome was located in the PstI K fragment (Fig.  SB, lanes i and j) . The approximately 5- (Fig.  SB, lanes k and 1) . Since the H fragment was reported to be 6 kb in size (4), NruI cleavage resulted in the 5-kb product replacing the cleaved K fragment and a 1-kb fragment that was not resolved in the gel analysis. These data coupled with the NruI and SalI-NruI restriction data made it possible to map the two NruI sites in the SPP c2 d2 genome (Fig. 2 (Fig. 2) . The Fig. 3 ) is preceded by a sequence closely resembling the Shine-Dalgarno sequence (8) , and it would encode a protein of 201 amino acids (-22 kDa). Whether this is indeed the initiation codon for the d gene remains to be determined.
The transcriptional initiation site for the d gene is likely also contained within the PstI-EcoRI fragment. In CU1050(pJM160) cells, both biological expression of the d gene (by immunity test) and synthesis of the 22-kDa d protein were detected. In addition, the DNA fragment encoding the amino-terminal portion of the d gene (positions 1 to 540, Fig. 3 ) was fused to the E. coli lacZ coding sequence, and the fusion gene directed the synthesis of enzymatically active P-galactosidase in vivo in both E. coli and B. subtilis (unpublished data). These data also suggest that the d gene protein does not positively regulate its own expression.
The expression of the d gene is probably regulated in vivo. We detected a fair amount of d protein in CU1050(pJM160) cells by immunoblotting, but could not detect any d protein in CU1147, the strain carrying the SP, c2 prophage. Either the d gene is not normally expressed in the lysogen or the d protein is synthesized but sequestered or degraded so it is not detectable under the conditions used for the preparation of the cell extracts.
Cloned d gene confers on its host immunity to superinfecting phages. The lack of observable lytic growth is not due to efficient lysogeny of the infecting SP, phage as was shown by using the SPP::Tn917 cl phage to infect CU1050 subtilis is unable to stably maintain SP,B cl d2 at the prophage state, this result was not unexpected. On the other hand, it has been shown that mixed infection of SPP cl and c2 produces double lysogens (13) . If the d gene product acts in trans and d2 is a recessive mutation, then one would also expect to obtain double lysogens carrying both SP, c2 d2 and SPI cl. Our failure to obtain such double lysogens suggests that the regulation of the lysogeny and immunity processes in SPP is complex. Possibly the d gene product has more than one regulatory role in controlling phage immunity and lysogenization.
